Craneware plc
20 July 2026
This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended. On publication of this announcement via a Regulatory Information Service, this information is considered to be in the public domain.
20 July 2026
Craneware plc
("Craneware" or the "Company")
Notice of Cyber Security Incident
Craneware (AIM: CRW.L), a leader in healthcare financial performance solutions, reports that it has identified and is responding to a cyber security incident involving unauthorised access to a subset of its data environment.
The Company's incident response plan has been activated, including the appointment by the Board of external cyber security and forensic specialists. Their investigation is ongoing, alongside the Craneware IT team and the Company's retained cyber security service providers.
The incident has been contained and there has been no disruption to customer services or to the Company's operations. The external specialists have confirmed that there are no residual indicators of compromise arising from the cyber security incident in the Company's systems
The Company has notified the relevant regulators and law enforcement agencies, including the Information Commissioner's Office in the UK and Federal Bureau of Investigations in the US.
Investigations so far have established that a significant volume of file names were viewed and exfiltrated. The current assessment is that a large element of the data involved is non-sensitive or already public regulatory data. A percentage of Craneware employee data as well as a subset of customer and partner records have been accessed and exfiltrated.
The Company is continuing to assess the precise nature and scope of all the data involved and is working with its advisers to identify affected parties and prepare appropriate notifications, including any required further notifications to relevant authorities, in each case in accordance with applicable regulatory obligations.
The Company will update the market as appropriate.
For further information, please contact:
|
Craneware plc |
+44 (0)131 550 3100 |
|
Keith Neilson, CEO |
|
|
Craig Preston, CFO |
|
|
Alma Strategic Communications |
+44 (0)20 3405 0205 |
|
Caroline Forde, Louisa El-Ahwal |
craneware@almastrategic.com |
|
Peel Hunt (NOMAD and Joint Broker) |
+44 (0)20 7418 8900 |
|
Neil Patel, Benjamin Cryer, Kate Bannatyne |
|
|
Investec Bank PLC (Joint Broker) |
+44 (0)20 7597 5970 |
|
Patrick Robb, Virginia Bull, Arnav Kapoor |
|
|
|
|
|
Berenberg (Joint Broker) |
+44 (0)20 3207 7800 |
|
Mark Whitmore, Tom Ballard, Patrick Dolaghan, Ryan Mahnke |
About Craneware
For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster - that simplify the complexities of healthcare finance and operations. What sets us apart is our unique combination of deep healthcare expertise and engineering excellence, positioning us as a strategic partner rather than just a technology provider. The Craneware Group empowers healthcare organizations to achieve sustainable financial success while delivering better outcomes for the communities they serve - today and in the future. Together, we are transforming the business of healthcare.
Learn more at www.thecranewaregroup.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.